Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

about

Trastuzumab and survival of patients with metastatic breast cancer.Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014).

P2860

Q40159320-813FB035-F10C-40BC-8D57-F8556587B03B Q47598844-B3FC29B4-468A-47E3-9C35-8C8B453444CC

P2860

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

Item

http://www.wikidata.org/entity/Q37100311

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 December 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Trastuzumab re-treatment follo ...... val: the HERA trial experience

@en

Trastuzumab re-treatment follo ...... al: the HERA trial experience.

@nl

type

Item

label

Trastuzumab re-treatment follo ...... val: the HERA trial experience

@en

Trastuzumab re-treatment follo ...... al: the HERA trial experience.

@nl

prefLabel

Trastuzumab re-treatment follo ...... val: the HERA trial experience

@en

Trastuzumab re-treatment follo ...... al: the HERA trial experience.

@nl

P1476

Trastuzumab re-treatment follo ...... val: the HERA trial experience

@en

P2093

Aron Goldhirsch

http://www.w3.org/2001/XMLSchema#string

Christian Jackisch

http://www.w3.org/2001/XMLSchema#string

David Cameron

http://www.w3.org/2001/XMLSchema#string

HREA Study Team

http://www.w3.org/2001/XMLSchema#string

Ian Smith

http://www.w3.org/2001/XMLSchema#string

Luca Gianni

http://www.w3.org/2001/XMLSchema#string

Magalie Krieguer

http://www.w3.org/2001/XMLSchema#string

Marion Procter

http://www.w3.org/2001/XMLSchema#string

Martine Piccart

http://www.w3.org/2001/XMLSchema#string

Otto Metzger-Filho

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Trastuzumab emtansine for HER2-positive advanced breast cancer.

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial.

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

Clinicopathological features among patients with advanced human epidermal growth factor-2-positive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study.

Effectiveness of trastuzumab in first-line HER2+ metastatic breast cancer after failure in adjuvant setting: a controlled cohort study.

Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.

P2888

s10549-015-3656-0

P304

127-132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3656-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26708471

http://www.w3.org/2001/XMLSchema#string

P932

4947530

http://www.w3.org/2001/XMLSchema#string

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

about

P2860

P2860

Trastuzumab re-treatment following adjuvant trastuzumab and the importance of distant disease-free interval: the HERA trial experience

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932